This gaming company could become your most profitable short to date. That's not a statement we make lightly either, considering what we've accomplished so far.
But because this overinflated, overvalued firm is out of touch with the technological changes that threaten its existence, the profit potential here could be even greater.
Here's your most promising short-selling opportunity of 2016 so far...
This gaming company could become your most profitable short to date. That's not a statement we make lightly either, considering what we've accomplished so far.
But because this overinflated, overvalued firm is out of touch with the technological changes that threaten its existence, the profit potential here could be even greater.
Here's your most promising short-selling opportunity of 2016 so far...
Valeant Pharmaceuticals (NYSE: VRX) is the perfect example of everything that's wrong with the markets today.
In just one company, you find...
A risky, predatory, and destructive business model; extremely shady, allegedly illegal accounting and operating practices; $30 billion of debt on just $9 billion in the trailing 12 months; the most enthusiastic sell-side analysts money can buy; a huge number of investors who didn't realize they were exposed to this mess; and several hedge fund managers who should've known better...
Back in October 2015, when I realized how far and how fast this company's fall was going to be, I made the only recommendation I could in that situation:
Make a killing on Valeant's spectacular demise.
Now, Valeant is likely doomed as a company, and it's time to wind down this short-side profit play - with the gains we've had, there's no reason to chase it down any further. I'd like to see it fall further, personally, because it's a disgusting company, but there's no need to be greedy.
The very good news is there are plenty of other companies out there like it right now. In fact, I'm tracking one as I write this.
But... here's how we made as much as 700% as this stock crashed...
Conventional wisdom is that "rising water raises all boats," but that's not always the case.
Despite October's market rebound, all four of the companies I told you were ripe for failure are down double digits since I brought them to your attention as stocks to short.
And these stocks still have plenty of downside ahead. Here's how to play the situation...
On Tuesday, Morgan Stanley analysts cut their target price for GoPro stock. Millions of investors were surprised, and the stock got shellacked.
GoPro is a worse value trap now than ever, and any investor who gets sucked in now is playing with fire.
I know the temptation is to buy, but hold your ground. The company has always been on the "cusp of something great," and it's never delivered.
GoPro Inc. (Nasdaq: GPRO) continues to defy the odds thanks to a litany of headlines and experts who just "know" the stock is going to rebound.
Call me crazy, but that's about as possible as FedEx painting its truck fleet brown. I think GoPro stock is worth $15 a share... at best.
Today we've got three iconic stocks to short that aren't identifiable to everyone. Because there's only one reliable metric investors can use to recognize these seemingly pristine companies.
And our timing couldn't be better, since corporate profit growth is about to go negative and fears of another recession mount.
Here are the lucrative picks to profit from and why most investors are missing them...
We may still be in a bull market, but the ground is becoming more fertile for short selling.
At some point, the market is going to catch on as to why the markets have been surging so high for so long - years of money-printing by the world's central banks. That means now is a great time to look for short selling candidates.
And here are three stocks ripe for short selling right now...
